rozerem Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Rozerem, and what generic alternatives are available?

Rozerem is a drug marketed by Takeda Pharms Usa and is included in one NDA.

The generic ingredient in ROZEREM is ramelteon. There are three drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the ramelteon profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Rozerem

A generic version of rozerem was approved as ramelteon by DR REDDYS LABS SA on July 26^th, 2013.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for rozerem?
What are the global sales for rozerem?
What is Average Wholesale Price for rozerem?

Summary for rozerem

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	110
Clinical Trials:	46
Patent Applications:	2,026
Drug Prices:	Drug price information for rozerem
What excipients (inactive ingredients) are in rozerem?	rozerem excipients list
DailyMed Link:	rozerem at DailyMed

Drug patent expirations by year for rozerem

Recent Clinical Trials for rozerem

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Brigham and Women's Hospital	Phase 4
Rhode Island Hospital	Phase 4
State University of New York at Buffalo	Phase 4

See all rozerem clinical trials

Pharmacology for rozerem

Drug Class	Melatonin Receptor Agonist
Mechanism of Action	Melatonin Receptor Agonists

Paragraph IV (Patent) Challenges for ROZEREM

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
ROZEREM	Tablets	ramelteon	8 mg	021782	2	2009-07-22

US Patents and Regulatory Information for rozerem

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Takeda Pharms Usa	ROZEREM	ramelteon	TABLET;ORAL	021782-001	Jul 22, 2005	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for rozerem

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Takeda Pharms Usa	ROZEREM	ramelteon	TABLET;ORAL	021782-001	Jul 22, 2005	⤷ Sign Up	⤷ Sign Up
Takeda Pharms Usa	ROZEREM	ramelteon	TABLET;ORAL	021782-001	Jul 22, 2005	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for rozerem

See the table below for patents covering rozerem around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Norway	983970		⤷ Sign Up
Japan	2002212063	COPOLYVIDONE-CONTAINING PHARMACEUTICAL PREPARATION	⤷ Sign Up
Hong Kong	1087112		⤷ Sign Up
Hungary	224220	Triciklusos vegyületek, eljárás előállításukra és alkalmazásuk (TRICYCLIC COMPOUNDS, THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS AND USE)	⤷ Sign Up
Australia	2231897		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration